Do randomised clinical trials influence practice? The example of cerebral vein and dural sinus thrombosis [2]

Journal of Neurology

Volumn 249, Issue 11, 2002, Pages 1595-1596

  Ferro, José M ^a   Lopes, Gabriela C ^b   Rosas, Maria José ^c   Bravo Marques, José M ^d   Costa, José B ^e  

^a Centro de Estudos Egas Moniz   (Portugal)

^b Anesthesiology and Intensive Care Unit   (Portugal)

^c HOSPITAL DE SÃO JOÃO   (Portugal)

^d INSTITUTO PORTUGUÊS DE ONCOLOGIA DE LISBOA FRANCISCO GENTIL   (Portugal)

^e Hospital Capuchos   (Portugal)

Author keywords

[No Author keywords available]

Indexed keywords

HEPARIN; LOW MOLECULAR WEIGHT HEPARIN;

ANTICOAGULATION; BRAIN VEIN; CEREBRAL SINUS THROMBOSIS; CLINICAL TRIAL; CONFIDENCE INTERVAL; DISEASE SEVERITY; HUMAN; INTRACRANIAL HYPERTENSION; LETTER; PORTUGAL; PRACTICE GUIDELINE; PRIORITY JOURNAL; RANDOMIZATION; TREATMENT OUTCOME; VEIN THROMBOSIS;

ACADEMIC MEDICAL CENTERS; CLINICAL PROTOCOLS; DOSE-RESPONSE RELATIONSHIP, DRUG; EDUCATION, MEDICAL, CONTINUING; EXPERT TESTIMONY; HEPARIN; HUMANS; INJECTIONS, INTRAVENOUS; INJECTIONS, SUBCUTANEOUS; RANDOMIZED CONTROLLED TRIALS; SINUS THROMBOSIS, INTRACRANIAL; VENOUS THROMBOSIS;

EID: 0036459953     PISSN: 03405354     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00415-002-0847-5     Document Type: Letter

References (10)

1. Bousser M-G (2000) Cerebral venous thrombosis. Nothing, heparin or local thrombolysis? J Neurol 247:252-258
2. Brucker AB, Vollert-Rogenhofer H, Wagner M, Stieglbauer K, Felber S, Trenkler J, Deisenhammer E, Aichner F (1998) Heparin treatment in acute cerebral sinus venous thrombosis: A retrospective clinical and MR analysis of 42 cases. Cerebrovasc Dis 8:331-337
3. Conti CR, Cooper-DeHoff RM (2001) How will INVEST and other hypertension trials change clinical practice? Clin Cardiol 24(suppl 11):24-29
4. de Bruijn SF, Stam J (1999) Randomized, placebo-controlled trial of anticoagulant treatment with low-molecular-weight heparin for cerebral sinus thrombosis. Stroke 30:484-488
5. Einhäupl KM, Villringer A, Meister W, Mehraein S, Garner C, Pellkofer M, Haberl RL, Pfister HW, Schmiedek P (1991) Heparin treatment in sinus venous thrombosis. Lancet 338:597-600
6. Ferro JM, Correia, Pontes C, Baptista MV, Pita for the Cerebral Venous Thrombosis Portuguese Collaborative Study Group (VENOPORT) (2001) Cerebral vein and dural sinus thrombosis in Portugal: 1980-1998 Cerebrovasc Dis 11:177-182
7. Frykman V, Beerman B, Ryden L, Rosenqvist M (2001) Management of atrial fibrillation: Discrepancy between guideline recommendations and actual practice exposes patients to risk for complications. Eur Heart J 20:1954-1959
8. Holloway RG, Benesch C, Rush SR (2000) Stroke prevention: Narrowing the evidence-practice gap. Neurology 23:1899-1906
9. McCormick D, Gurwitz JH, Goldberg RJ, Becker R, Tate JP, Elwell A, Radford MJ (2001) Prevalence and quality of warfarin use for patients with atrial fibrillation in the long-term care setting. Arch Intern Med 161:2458-2463
10. Stam J, de Bruijn SFTM for the CVST study group (1997) Dutch-European Cerebral Sinus Thrombosis Trial: Final results. Cerebrovasc Dis 7(suppl 4):8